Acquired
Novo Nordisk (Ozempic)
David Rosenthal
Because H.C. Hagedorn, he himself led the research developing this and he puts his own name on it. Kind of tells you what you need to know about him. This is much more stable and needs to be injected fewer times per day, which is a huge benefit for patients. So Nordisk, rather than building up production facilities around the world, what they decide to do is license it
0
💬
0
Comments
Log in to comment.
There are no comments yet.